Cart
sales@molnova.com
Pro-xylane
CAS No. 439685-79-7
Pro-xylane( Hydroxypropyl tetrahydropyrantriol )
Catalog No. M21826 CAS No. 439685-79-7
Pro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePro-xylane
-
NoteResearch use only, not for human use.
-
Brief DescriptionPro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
-
DescriptionPro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis. Pro-xylane is the first example of 'Green' chemical used in cosmetic.
-
In Vitro——
-
In Vivo——
-
SynonymsHydroxypropyl tetrahydropyrantriol
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number439685-79-7
-
Formula Weight192.21
-
Molecular FormulaC?H??O?
-
Purity>98% (HPLC)
-
SolubilityH2O : 250 mg/mL (1300.66 mM; Need ultrasonic)；DMSO : ≥ 83.33 mg/mL (433.54 mM)
-
SMILESCC(O)C[C@H]1[C@@H]([C@H]([C@H](O)CO1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cavezza A, et al. Synthesis of Pro-Xylane: a new biologically active C-glycoside in aqueous media. Bioorg Med Chem Lett. 2009 Feb 1;19(3):845-9.
molnova catalog
related products
-
EP1-antagonist-1
EP1-antagonist-1 is an EP1 antagonist (pKi: 7.54; pIC50: 8.5).
-
Monoethyl pimelate
Monoethyl pimelate is a PROTAC linker, which refers to the alkyl/ether composition.
-
Letaplimab
Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.
